| DIRECT COMPETITOR COMPARISON | |
| QGLY | Pvt1 | MTXX | PRGO | Industry | | Market Cap: | 27.37M | N/A | 39.62M | 3.67B | 74.33M | | Employees: | 86 | 53,1001 | 34 | 7,250 | 43 | | Qtrly Rev Growth (yoy): | -21.70% | N/A | -23.80% | 15.90% | 3.00% | | Revenue (ttm): | 17.49M | 20.81B1 | 102.03M | 2.08B | 17.49M | | Gross Margin (ttm): | 53.86% | N/A | 71.65% | 30.24% | 63.53% | | EBITDA (ttm): | -6.73M | N/A | 14.03M | 365.56M | -6.12M | | Oper Margins (ttm): | -41.98% | N/A | 12.56% | 14.16% | -3.79% | | Net Income (ttm): | -7.59M | N/A | -9.87M | 163.82M | N/A | | EPS (ttm): | -0.587 | N/A | -1.072 | 1.793 | -0.19 | | P/E (ttm): | N/A | N/A | N/A | 22.39 | 15.29 | | PEG (5 yr expected): | N/A | N/A | N/A | 1.23 | 1.28 | | P/S (ttm): | 1.62 | N/A | 0.37 | 1.79 | 3.39 |
|
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 56.35 | -0.27% | 57.03B | 12.29 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 46.94 | 0.04% | 13.57B | 15.71 | | Genzyme Corp. | GENZ | 50.70 | -0.72% | 13.45B | 28.91 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 46.11 | -0.97% | 41.50B | 17.83 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 49.78 | -0.34% | 8.88B | 1015.92 | | Teva Pharmaceutical Industries Limited | TEVA | 52.79 | -0.17% | 46.51B | 48.30 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 37.09 | 0.35% | 3.94B | 19.12 | | Barr Pharmaceuticals, Inc. | Private - View Profile | | King Pharmaceuticals Inc. | KG | 11.83 | -1.00% | 2.94B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 17.87 | -0.78% | 5.46B | 109.63 | | Pfizer Inc. | PFE | 18.17 | -0.44% | 146.62B | 15.09 | | Johnson & Johnson | JNJ | 62.84 | -0.08% | 173.38B | 13.72 | | GlaxoSmithKline plc | GSK | 41.47 | -1.87% | 105.13B | 13.17 | | Sanofi-Aventis | SNY | 37.96 | -1.22% | 99.12B | N/A |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Novartis AG | NVS | 55.60 | 0.40% | 126.28B | 16.65 | | RHHBY.PK | 40.92 | -1.30% | N/A | N/A | | AstraZeneca plc | AZN | 44.83 | -1.02% | 65.00B | 9.00 | | Abbott Laboratories | ABT | 54.49 | 0.76% | 84.28B | 14.76 | | Bristol-Myers Squibb Co. | BMY | 25.31 | -0.28% | 50.14B | 13.09 |
|
| NEWS ON DIRECT COMPETITORS | |
| • | MTXX | | Somaxon, Kimber Resources: Midday Volume Plays
Mon 1:17pm -
at TheStreet.com | | • | MTXX | | MATRIXX INITIATIVES INC Files SEC form 8-K, Other Events
Mon 12:31pm -
EDGAR Online | | • | PRGO | | Israel Stocks: Israel stocks off; Osem up, Migdal off on reports
Sun 8:38am -
at MarketWatch | | • | PRGO | | A Relative Price Strength Screen for All Markets
Wed, Nov 25 -
Zacks.com | | • | MTXX | | Smell Your Way To Profits
Tue, Nov 24 -
at Investopedia | | • | PRGO | | Israel Stocks: Israel stocks steady; BarCap sees no rate change
Sun, Nov 22 -
at MarketWatch | | • | PRGO | | Flu season, ailing economy aiding Mich. drug maker
Fri, Nov 20 -
AP | | • | MTXX | | MATRIXX INITIATIVES INC Files SEC form 8-K, Other Events
Thu, Nov 19 -
EDGAR Online | | • | PRGO | | Perrigo Company To Present at the Sidoti Emerging Growth Conference
Thu, Nov 19 -
PR Newswire | | • | PRGO | | Israel Stocks: Israel benchmarks steady; Elbit, Formula report
Wed, Nov 18 -
at MarketWatch | | • | MTXX | | MATRIXX INITIATIVES INC Financials
Fri, Nov 13 -
EDGAR Online Financials | | | All Headlines for these symbols... |
|
|
|
0.34% Nasdaq 
0.08 (3.67%) 
Competitors
